Filing Details
- Accession Number:
- 0001209191-16-107020
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-03-08 17:02:04
- Reporting Period:
- 2016-03-04
- Filing Date:
- 2016-03-08
- Accepted Time:
- 2016-03-08 17:02:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1245104 | Globeimmune Inc | GBIM | Pharmaceutical Preparations (2834) | 841353925 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1262327 | Augustine Lawlor | C/O Healthcare Ventures Llc 47 Thorndike Street, Suite B1-1 Cambridge MA 02141 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2016-03-04 | 5,000 | $1.05 | 503,277 | No | 4 | S | Indirect | By Partnership |
| Common Stock | Disposition | 2016-03-07 | 5,010 | $0.99 | 498,267 | No | 4 | S | Indirect | By Partnership |
| Common Stock | Disposition | 2016-03-08 | 5,000 | $1.10 | 493,267 | No | 4 | S | Indirect | By Partnership |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By Partnership |
| No | 4 | S | Indirect | By Partnership |
| No | 4 | S | Indirect | By Partnership |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.03 to $1.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote (1) to this Form 4.
- These securities are held of record by HealthCare Ventures VII, L.P. ("HCVVII"). HealthCare Partners VII, L.P. ("HCPVII") is the General Partner of HCVVII. Mr. Lawlor, a member of the Board of Directors of the Issuer, is a general partner of HCPVII and, as such, exercises shared voting and investment power with respect to the shares owned by HCVVII. Mr. Lawlor disclaims beneficial ownership of such securities, except to the extent of his proportionate pecuniary interest therein and this report shall not be deemed an admission that he is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.81 to $1.03, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote (3) to this Form 4
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.10 to $1.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote (4) to this Form 4
Billionaire Hedge Funds
